NCT05677217View on ClinicalTrials.gov

Clinical Feasibility of Nab-paclitaxel Plus Gemcitabine-cisplatin Chemotherapy in Locally Advanced Cholangiocarcinoma

RecruitingOBSERVATIONAL

Enrollment

100

Participants

Timeline

Start Date

March 20, 2023

Primary Completion Date

September 30, 2024

Study Completion Date

November 30, 2024

Conditions

Locally Advanced Cholangiocarcinoma

Trial Locations (1)

13496

RECRUITING

CHA Bundang Medical Center, Seongnam-si

All Listed Sponsors

lead

CHA University

OTHER